The change of the quantitative HBsAg level during the natural course of chronic hepatitis B

Liver International - Tập 31 Số 6 - Trang 817-823 - 2011
Yu J. Kim1, Hyun C. Cho1, Moon Seok Choi1, Joon‐Hyung Lee1, Kwang Cheol Koh1, Byung Chul Yoo1, Seung Woon Paik1
1Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

Tóm tắt

Từ khóa


Tài liệu tham khảo

Fung, 2010, Hepatitis B virus DNA and hepatitis B surface antigen levels in chronic hepatitis B, Expert Rev Anti Infect Ther, 8, 717, 10.1586/eri.10.45

Lok, 2009, Chronic hepatitis B, update 2009, 50, 661

European Association for the Study of the Liver., 2009, EASL Clinical Practice Guidelines, management of chronic hepatitis B, 50, 227

Brunetto, 2010, A new role for an old marker, HBsAg, J Hepatol, 52, 475, 10.1016/j.jhep.2009.12.020

Manesis, 2007, Prediction of treatment-related HBsAg loss in HBeAg-negative chronic hepatitis B, a clue from serum HBsAg levels, 12, 73

Tangkijvanich, 2009, Low pretreatment serum HBsAg level and viral mutations as predictors of response to PEG-interferon alpha-2b therapy in chronic hepatitis B, J Clin Virol, 46, 117, 10.1016/j.jcv.2009.07.005

Brunetto, 2009, Hepatitis B virus surface antigen levels, a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B, 49, 1141

Moucari, 2009, Early serum HBsAg drop, a strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients, 49, 1151

Jung, 2010, Change in serum hepatitis B surface antigen level and its clinical significance in treatment-naïve, hepatitis B e antigen-positive patients receiving entecavir, J Clin Gastroenterol, 44, 653, 10.1097/MCG.0b013e3181d52946

Jaroszewicz, 2010, Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection, a European perspective, 52, 514

Nguyen, 2010, Hepatitis B surface antigen levels during the natural history of chronic hepatitis B, a perspective on Asia, 52, 508

Thompson, 2010, Serum hepatitis B surface antigen and hepatitis B e antigen titers, disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers, 51, 1933

Song, 2005, Hepatitis B virus genotypes in Korea, an endemic area of hepatitis B virus infection, 48, 133

Cho, 2009, Distribution of hepatitis B virus genotypes in Korea, Korean J Hepatol, 15, 140, 10.3350/kjhep.2009.15.2.140

Lee, 2010, Long-term adefovir dipivoxil monotherapy for up to 5 years in lamivudine-resistant chronic hepatitis B, Antivir Ther, 15, 235, 10.3851/IMP1510

Deguchi, 2004, Quantitation of hepatitis B surface antigen by an automated chemiluminescent microparticle immunoassay, J Virol Methods, 115, 217, 10.1016/j.jviromet.2003.10.002

Nguyen, 2009, The role of quantitative hepatitis B serology in the natural history and management of chronic hepatitis B, Hepatol Int, 3, S5, 10.1007/s12072-009-9149-7

Yim, 2006, Natural history of chronic hepatitis B virus infection, what we knew in 1981 and what we know in 2005, 43, S173

Hadziyannis, 2001, Hepatitis B e antigen-negative chronic hepatitis B, Hepatology, 34, 617, 10.1053/jhep.2001.27834

Rodella, 2006, Quantitative analysis of HBsAg, IgM anti-HBc and anti-HBc avidity in acute and chronic hepatitis B, J Clin Virol, 37, 206, 10.1016/j.jcv.2006.06.011

Chan, 2007, Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response, Clin Gastroenterol Hepatol, 5, 1462, 10.1016/j.cgh.2007.09.005

Lu, 2008, Correlation between HBV cccDNA and HBsAg levels and their reduction by peginterferon alfa-2a based therapy in patients with chronic hepatitis B, Hepatology, 48, S746A

Manesis, 2008, HBsAg serum levels correlate with total liver HBV DNA but not with cccDNA, Hepatology, 48, S746A

Kohmoto, 2005, Quantitative detection of hepatitis B surface antigen by chemiluminescent microparticle immunoassay during lamivudine treatment of chronic hepatitis B virus carriers, J Med Virol, 75, 235, 10.1002/jmv.20262

Wiegand, 2008, A decline in hepatitis B virus surface antigen (HBsAg) predicts clearance, but does not correlate with quantitative hbeag or HBV DNA levels, Antivir Ther, 13, 547, 10.1177/135965350801300402

Kuhns, 2004, Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc, implications for future HBV screening policy, 44, 1332